Latest News

[September 2009]
Microbionta
Microbionta signed an agreement with the Protemics group at the Universidad Complutense de Madrid.
More info

[February 2009]
Microbionta
The AntiPathoGN consortium meets for the first time to establish a set of criteria and priorities.
More info

[March 2008]
Microbionta
The European Union awarded a research grant to a consortium formed by Microbionta S.L.....
More info

Welcome to microbionta

Microbionta is a new company that develops novel technologies for use in diagnostics and therapy based on the expression of antibodies and antibody-like molecules in bacteria.
We have developed proprietary technologies for the production of recombinant antibodies in bacteria that represent an improvement over existing methods. In addition, we have created tools for the efficient selection and display of antibodies and antibody-like molecules in bacteria.